ReviewJournal of clinical medicine2021
Non-Adhesive Liquid Embolic Agents in Extra-Cranial District: State of the Art and Review of the Literature.
Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Endoscopic, endoscopic-assisted and open approaches in the treatment of juvenile angiofibroma: what has been new in the past decade (and 1586 cases)?European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023Pooled it
- Transarterial Embolization for Malignancy-Related Gastrointestinal Bleeding: Outcomes with and Without CT Extravasation.Diagnostics (Basel, Switzerland) · 2026Article
- Dangerous Ophthalmic Anastomoses During Middle Meningeal Artery Embolization: Anatomical Pitfalls, Hemodynamic Mechanisms, and an Illustrative Case of Delayed Visual Loss.Clinical neuroradiology · 2026Review
- Liquid embolic agents-a practical overview.CVIR endovascular · 2026Review
- Embolic agents in emergency care: a large retrospective cohort study.CVIR endovascular · 2026Article
- Management of spontaneous abdominal wall hematomas: a narrative review with a focus on CTA-negative endovascular cases.CVIR endovascular · 2026Review
- Safety and efficacy analysis of different embolization methods of Glubran-2 glue in the treatment of arterial gastrointestinal bleeding.BMC surgery · 2025Article
- Medium- and Long-Term Evaluation of Splenic Arterial Embolization: A Retrospective CT Volumetric and Hematologic Function Analysis.Journal of personalized medicine · 2025Article
- Symptomatic arteriovenous malformation and peripheral arterial disease treated with intra-vascular lithotripsy and coil embolization.Journal of vascular surgery cases and innovative techniques · 2025Article
- Transarterial embolization for acute lower gastrointestinal bleeding: a retrospective bicentric study.La Radiologia medica · 2025Article
- OnyxGels (Basel, Switzerland) · 2024Review
- Primary and secondary postpartum haemorrhage: a review for a rationale endovascular approach.CVIR endovascular · 2024Review
- The Advantages of Non-Adhesive Gel-like Embolic Materials in the Endovascular Treatment of Benign Hypervascularized Lesions of the Head and Neck.Gels (Basel, Switzerland) · 2023Article
- Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs).Medicina (Kaunas, Lithuania) · 2023Article
- A Multicenter Retrospective Cohort Study Evaluating the Clinical Outcomes of Patients with Coagulopathy Undergoing Transcatheter Arterial Embolization (TAE) for Acute Non-Neurovascular Bleeding.Medicina (Kaunas, Lithuania) · 2023Article
- Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding.Medicina (Kaunas, Lithuania) · 2023Article
- Pulmonary Artery Pseudoaneurysms Embolization: Bicentric Experience and Review of the Literature.Journal of clinical medicine · 2023Article
- Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH).Journal of clinical medicine · 2023Article
- Efficacy and Safety of Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs) in Transcatheter Arterial Embolization (TAE) of Acute Non-Neurovascular Bleeding: A Multicenter Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review focuses on the use of "new" generation of non-adhesive liquid embolic agents (NALEA). In literature, non-adhesive liquid embolic agents have mainly been used in the cerebral district; however, multiple papers describing the use of NALEA in the extracranial district have been published recently and the aim of this review is to explore and analyze this field of application. There are a few NALEA liquids such as Onyx, Squid, and Phil currently available in the market, and they are used in the following applications: mainly arteriovenous malformations, endoleaks, visceral aneurysm or pseudoaneurysm, presurgical and hypervascular lesions embolization, and a niche of percutaneous approaches. These types of embolizing fluids can be used alone or in combination with other embolizing agents (such as coils or particles) so as to enhance its embolizing effect or improve its possible defects. The primary purpose of this paper is to evaluate the use of NALEAs, predominantly used alone, in elective embolization procedures. We did not attempt a meta-analysis due to the data heterogeneity, high number of case reports, and the lack of a consistent follow-up time period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.